IGFBP1 and breast carcinoma: Moreover, IGFBP1 (at concentrations of 800 ng/mL or higher) can interact with integrin receptors to induce focal adhesion kinase (FAK) dephosphorylation, and the detachment and apoptosis of breast cancer cells [21].